Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Tweeting
View:
Post by Pareto8020 on Jul 09, 2021 12:32pm

Tweeting

Looks like SBM is back to retweeting and responding to articles, etc. on Twitter.

They reTweeted a couple articles about SGLT2 compounds being used for heart and cardiovascular issues.  Wonder if that is their subtle way of telling shareholders that is what they have been expanding their SGLT2 use to as well.  

Good to have another use but damn I would just like them to finalize a contract or anything at this point before flying off in another direction.  They are like cats toying with a mouse - playing with it....batting it around but never quite  executing it.  Then off to the next spot the laser shines on.  Just FINISH something - it shouldn't be this painful or difficult! Get the hell out of your own ways.

Comment by Crazydan on Jul 11, 2021 4:39pm
Pareto8020 The day that you are going to realize that Howard "as no cash money involve in that sh$t show" He is in no hurry to have anything done. He is collecting is salary by doing almost nothing. No July presentation!!! No annual meeting!!!! I'm so glad I'm out of this mess!!! GLTA anyway
Sirona Biochem Corp
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities